XML 25 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 434 $ 135
Accounts receivable, net of allowance for doubtful accounts of $15 as of both September 30, 2019 and December 31, 2018 1,117 1,012
Inventories 112 99
Prepaid expenses and other current assets 116 144
Total current assets 1,779 1,390
Property, plant and equipment, net 1,351 1,288
Operating lease right-of-use assets 508 0
Goodwill 6,617 6,563
Intangible assets, net 1,138 1,207
Investment in equity method investees 474 436
Other assets 152 119
Total assets 12,019 11,003
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,059 1,021
Current portion of long-term debt 805 464
Current portion of long-term operating lease liabilities 147 0
Total current liabilities 2,011 1,485
Long-term debt 3,188 3,429
Long-term operating lease liabilities 405 0
Other liabilities 685 745
Commitments and contingencies
Redeemable noncontrolling interest 76 77
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2019 and December 31, 2018; 217 shares issued as of both September 30, 2019 and December 31, 2018 2 2
Additional paid-in capital 2,705 2,667
Retained earnings 7,992 7,602
Accumulated other comprehensive loss (55) (59)
Treasury stock, at cost; 82 shares as of both September 30, 2019 and December 31, 2018 (5,039) (4,996)
Total Quest Diagnostics stockholders' equity 5,605 5,216
Noncontrolling interests 49 51
Total stockholders' equity 5,654 5,267
Total liabilities and stockholders' equity $ 12,019 $ 11,003